SGMO Financial Facts

Research and development: 15.27M
Total revenues: 3.94M
See Full Income Statement

Cash and cash equivalents: 33.01M
Prepaid expenses: 588K
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date 8/3/16 EPS Growth Rate -41.2%
Average EPS % Beat Rate +6.5% Revenue Growth Rate -36.0%
Average % Move 1-Wk after EPS -3.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/3/16 Q216 N/A-$0.24 N/A N/A$5.38M = N/A N/A
5/2/16 Q116 -$0.23-$0.24 +$0.01$3.94M$5.49M = Details
2/9/16 Q415 -$0.20-$0.21 +$0.01$9.1M$9.86M = Details
10/28/15 Q315 -$0.13-$0.25 +$0.12$8.6M$13.09M = Details
8/5/15 Q215 -$0.17-$0.13 -$0.04$8.4M$14.72M = Details
4/22/15 Q115 -$0.08-$0.14 +$0.06$13.5M$12.5M = Details
2/10/15 Q414 -$0.06-$0.09 +$0.03$14.95M$14.5M = Details
10/22/14 Q314 -$0.11-$0.14 +$0.03$12.4M$8.27M = Details